Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Clin Interv Aging
2023 Jan 01;18:1813-1825. doi: 10.2147/CIA.S422371.
Show Gene links
Show Anatomy links
Can We Slow Down Biological Age Progression? Study Protocol for the proBNPage Reduction (PBAR) Randomized, Double-Blind, Placebo-Controlled Trial (Effects of 4 "Anti-Aging" Food Supplements in Healthy Older Adults).
Muscari A
,
Forti P
,
Brizi M
,
Magalotti D
,
Capelli E
,
Potì S
,
Piro F
,
Pandolfi P
,
Perlangeli V
,
Ramazzotti E
,
Barbara G
,
PBAR Study Group
.
???displayArticle.abstract???
PURPOSE: The availability of a simple and reliable marker of biological age might allow an acceleration of the research in the field of longevity extension. Previous studies suggest that this marker might be the N-terminal of B-type natriuretic peptide precursor (NT-proBNP), from which proBNPage, a biological age surrogate, can be calculated. Objectives of the study: 1) To fine-tune the method of proBNPage progression assessment and 2) To establish whether 4 "anti-aging" treatments, which provided promising results in previous studies, can modify proBNPage progression.
PATIENTS AND METHODS: This is a double-blind randomized placebo-controlled clinical trial on 120 adults aged 65-80 years, free of cardiovascular diseases. Participants will be randomized into 3 groups: A) Coenzyme Q10 100 mg bid + Selenium 100 mcg; B) Resveratrol 350 mg bid + TA-65 (Astragalus Membranaceus extract) 100U; C) Placebo-1 bid + Placebo-2. They will be followed for 2 years and checked 8 times, to assess both proBNPage progression and treatment safety. Secondary variables (handgrip strength, aerobic capacity at the step test and quality of life) will also be assessed. Primary outcome will be the demonstration of significant changes of proBNPage, compared to baseline, in the 3 groups at 6, 12, 18 and 24 months. Secondary outcome will be the demonstration of similar changes of secondary variables. Statistical analyses will be mainly performed by repeated measures ANOVA (both according to intention to treat and per protocol) and paired t tests. The study was approved by the Ethics Committee Area Vasta Emilia Centro, Emilia-Romagna Region, ID: 64/2022/Sper/AOUBo. Trial registration: ClinicalTrials.gov, NCT05500742.
CONCLUSION: The use of proBNPage as a surrogate of biological age may prove an easy method to select anti-aging treatments worthy of further, more complex assessments.
Alehagen,
Cardiovascular mortality and N-terminal-proBNP reduced after combined selenium and coenzyme Q10 supplementation: a 5-year prospective randomized double-blind placebo-controlled trial among elderly Swedish citizens.
2013, Pubmed
Alehagen,
Cardiovascular mortality and N-terminal-proBNP reduced after combined selenium and coenzyme Q10 supplementation: a 5-year prospective randomized double-blind placebo-controlled trial among elderly Swedish citizens.
2013,
Pubmed
Aubert,
Telomere dynamics and aging.
2014,
Pubmed
Aune,
Dietary intake and blood concentrations of antioxidants and the risk of cardiovascular disease, total cancer, and all-cause mortality: a systematic review and dose-response meta-analysis of prospective studies.
2018,
Pubmed
Baur,
Resveratrol improves health and survival of mice on a high-calorie diet.
2006,
Pubmed
Bjelakovic,
Antioxidant supplements and mortality.
2014,
Pubmed
Boccardi,
Telomerase activation: a potential key modulator for human healthspan and longevity.
2014,
Pubmed
Boccardi,
A new pleiotropic effect of statins in elderly: modulation of telomerase activity.
2013,
Pubmed
Brown,
Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis.
2010,
Pubmed
Chan,
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials.
2013,
Pubmed
Chan,
Pathogenesis and management of the diabetogenic effect of statins: a role for adiponectin and coenzyme Q10?
2015,
Pubmed
Crimmins,
Quest for a summary measure of biological age: the health and retirement study.
2021,
Pubmed
Dow,
Evaluation of an oral telomerase activator for early age-related macular degeneration - a pilot study.
2016,
Pubmed
Engelsen,
[Effect of Coenzyme Q10 and Ginkgo biloba on warfarin dosage in patients on long-term warfarin treatment. A randomized, double-blind, placebo-controlled cross-over trial].
2003,
Pubmed
EuroQol Group,
EuroQol--a new facility for the measurement of health-related quality of life.
1990,
Pubmed
Fernandez,
TA-65, A Telomerase Activator improves Cardiovascular Markers in Patients with Metabolic Syndrome.
2018,
Pubmed
Fu,
Acute, subacute toxicity and genotoxic effect of Bio-Quinone Q10 in mice and rats.
2009,
Pubmed
Ghanim,
An antiinflammatory and reactive oxygen species suppressive effects of an extract of Polygonum cuspidatum containing resveratrol.
2010,
Pubmed
Giovannini,
Selenium Concentrations and Mortality among Community-Dwelling Older Adults: Results from IlSIRENTE Study.
2018,
Pubmed
Hannum,
Genome-wide methylation profiles reveal quantitative views of human aging rates.
2013,
Pubmed
Harris,
Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.
2009,
Pubmed
Hector,
The effect of resveratrol on longevity across species: a meta-analysis.
2012,
Pubmed
Horvath,
DNA methylation age of human tissues and cell types.
2013,
Pubmed
Johnson,
The plasma metabolome as a predictor of biological aging in humans.
2019,
Pubmed
Kalén,
Age-related changes in the lipid compositions of rat and human tissues.
1989,
Pubmed
Katz,
A measure of primary sociobiological functions.
1976,
Pubmed
Kim,
Quantitative measures of healthy aging and biological age.
2015,
Pubmed
Lam,
Resveratrol vs. calorie restriction: data from rodents to humans.
2013,
Pubmed
Landbo,
[Interaction between warfarin and coenzyme Q10].
1998,
Pubmed
Lawton,
Assessment of older people: self-maintaining and instrumental activities of daily living.
1969,
Pubmed
Li,
Effect of resveratrol and pterostilbene on aging and longevity.
2018,
Pubmed
Liu,
A new aging measure captures morbidity and mortality risk across diverse subpopulations from NHANES IV: A cohort study.
2018,
Pubmed
Lohman,
Predictors of Biological Age: The Implications for Wellness and Aging Research.
2021,
Pubmed
Loke,
Reference ranges for natriuretic peptides for diagnostic use are dependent on age, gender and heart rate.
2003,
Pubmed
Luchner,
Long-term pattern of brain natriuretic peptide and N-terminal pro brain natriuretic peptide and its determinants in the general population: contribution of age, gender, and cardiac and extra-cardiac factors.
2013,
Pubmed
McKie,
Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide: biomarkers for mortality in a large community-based cohort free of heart failure.
2006,
Pubmed
Menni,
Circulating Proteomic Signatures of Chronological Age.
2015,
Pubmed
Mortensen,
The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial.
2014,
Pubmed
Muscari,
N-terminal pro B-type natriuretic peptide (NT-proBNP): a possible surrogate of biological age in the elderly people.
2021,
Pubmed
Muscari,
The association of proBNPage with manifestations of age-related cardiovascular, physical, and psychological impairment in community-dwelling older adults.
2021,
Pubmed
Muscari,
A comparison of risk factors as predictors of cardiovascular and non-cardiovascular mortality in the elderly people--relevance of N-terminal pro-B-type natriuretic peptide and low systolic blood pressure.
2013,
Pubmed
Patel,
Clinical trials of resveratrol.
2011,
Pubmed
Perna,
Epigenetic age acceleration predicts cancer, cardiovascular, and all-cause mortality in a German case cohort.
2016,
Pubmed
Petrella,
A self-paced step test to predict aerobic fitness in older adults in the primary care clinic.
2001,
Pubmed
Rayman,
Effect of long-term selenium supplementation on mortality: Results from a multiple-dose, randomised controlled trial.
2018,
Pubmed
Redfield,
Plasma brain natriuretic peptide concentration: impact of age and gender.
2002,
Pubmed
Rockwood,
A Frailty Index Based On Deficit Accumulation Quantifies Mortality Risk in Humans and in Mice.
2017,
Pubmed
Sadowska-Bartosz,
Effect of antioxidants supplementation on aging and longevity.
2014,
Pubmed
Salvador,
A Natural Product Telomerase Activator Lengthens Telomeres in Humans: A Randomized, Double Blind, and Placebo Controlled Study.
2016,
Pubmed
Sanders,
Telomere length in epidemiology: a biomarker of aging, age-related disease, both, or neither?
2013,
Pubmed
Savoia,
Assessing the construct validity of the Italian version of the EQ-5D: preliminary results from a cross-sectional study in North Italy.
2006,
Pubmed
Shaito,
Potential Adverse Effects of Resveratrol: A Literature Review.
2020,
Pubmed
Singh,
Effect of Low-Dose Rapamycin on Senescence Markers and Physical Functioning in Older Adults with Coronary Artery Disease: Results of a Pilot Study.
2016,
Pubmed
Sun,
Dietary selenium intake and mortality in two population-based cohort studies of 133 957 Chinese men and women.
2016,
Pubmed
Timmers,
Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans.
2011,
Pubmed
Walle,
Bioavailability of resveratrol.
2011,
Pubmed
Walters,
mTORC Inhibitors as Broad-Spectrum Therapeutics for Age-Related Diseases.
2018,
Pubmed
Wang,
Plasma natriuretic peptide levels and the risk of cardiovascular events and death.
2004,
Pubmed
Wang,
Impact of age and sex on plasma natriuretic peptide levels in healthy adults.
2002,
Pubmed
Wang,
Resveratrol-induced augmentation of telomerase activity delays senescence of endothelial progenitor cells.
2011,
Pubmed
Wang,
The effect of resveratrol on lifespan depends on both gender and dietary nutrient composition in Drosophila melanogaster.
2013,
Pubmed
Washburn,
The Physical Activity Scale for the Elderly (PASE): development and evaluation.
1993,
Pubmed
Waziry,
Quantification of biological age as a determinant of age-related diseases in the Rotterdam Study: a structural equation modeling approach.
2019,
Pubmed
Weichhart,
mTOR as Regulator of Lifespan, Aging, and Cellular Senescence: A Mini-Review.
2018,
Pubmed
Weindruch,
The retardation of aging in mice by dietary restriction: longevity, cancer, immunity and lifetime energy intake.
1986,
Pubmed
Xia,
Resveratrol reduces endothelial progenitor cells senescence through augmentation of telomerase activity by Akt-dependent mechanisms.
2008,
Pubmed
